Combining Placing a Synera Patch With Propofol/Lidocaine Mixture to Decrease Pain With IV Propofol Injection
NCT02240628 is a phase 4 interventional trial sponsored by The University of Texas Health Science Center, Houston. As of 18 Nov 2026, it is completed. It studies Lidocaine and Saline in Pain on IV Injection of Propofol.. The registry lists an enrollment of 76 participants at 1 site in 1 country. The registry lists a start date of 31 Aug 2014 and a primary completion date of 30 Sept 2015.
Key facts
Registry attributes as recorded on the ClinicalTrials.gov study record.
| Field | Value |
|---|---|
| Registry ID | NCT02240628 |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional trial |
| Lead sponsor | The University of Texas Health Science Center, Houston |
| Enrollment | 76 |
| Registered sites | 1 |
| Countries | 1 |
| Conditions | Pain on IV Injection of Propofol. |
| Drugs | Lidocaine and Saline |
| Start | 31 Aug 2014 |
| Primary completion | 30 Sept 2015 |
| Study completion | 30 Sept 2015 |
| Last update posted | 22 Jun 2016 |
Registered summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- samia khalil, M.D
The University of Texas Health Science Center, Houston
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Memorial Hermann Hospital
Houston
United States, by state
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Questions about NCT02240628
Each answer restates registry values shown on this page.
What is NCT02240628?
NCT02240628 is a phase 4 interventional trial sponsored by The University of Texas Health Science Center, Houston. It studies Lidocaine and Saline in Pain on IV Injection of Propofol..
Who leads NCT02240628?
The registry names samia khalil, M.D (principal investigator, The University of Texas Health Science Center, Houston) as the overall official.
Where does NCT02240628 run?
The registry lists 1 site in 1 country. Every site with a stated country is in one country: United States.
Which drugs does NCT02240628 study?
The registered drug and biological interventions are Lidocaine and Saline.
When did NCT02240628 end?
The registry lists a primary completion date of 30 Sept 2015 and a study completion date of 30 Sept 2015. The sponsor last updated the record on 22 Jun 2016.
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 18 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.